300 related articles for article (PubMed ID: 18162466)
1. The phosphatase PHLPP controls the cellular levels of protein kinase C.
Gao T; Brognard J; Newton AC
J Biol Chem; 2008 Mar; 283(10):6300-11. PubMed ID: 18162466
[TBL] [Abstract][Full Text] [Related]
2. PHLiPPing the switch on Akt and protein kinase C signaling.
Brognard J; Newton AC
Trends Endocrinol Metab; 2008 Aug; 19(6):223-30. PubMed ID: 18511290
[TBL] [Abstract][Full Text] [Related]
3. Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C.
Xiong X; Li X; Wen YA; Gao T
J Biol Chem; 2016 Nov; 291(48):25167-25178. PubMed ID: 27760826
[TBL] [Abstract][Full Text] [Related]
4. The chaperones Hsp90 and Cdc37 mediate the maturation and stabilization of protein kinase C through a conserved PXXP motif in the C-terminal tail.
Gould CM; Kannan N; Taylor SS; Newton AC
J Biol Chem; 2009 Feb; 284(8):4921-35. PubMed ID: 19091746
[TBL] [Abstract][Full Text] [Related]
5. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms.
Brognard J; Sierecki E; Gao T; Newton AC
Mol Cell; 2007 Mar; 25(6):917-31. PubMed ID: 17386267
[TBL] [Abstract][Full Text] [Related]
6. Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling.
Warfel NA; Newton AC
J Biol Chem; 2012 Feb; 287(6):3610-6. PubMed ID: 22144674
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of inhibition of sequestration of protein kinase C alpha/betaII by ceramide. Roles of ceramide-activated protein phosphatases and phosphorylation/dephosphorylation of protein kinase C alpha/betaII on threonine 638/641.
Kitatani K; Idkowiak-Baldys J; Hannun YA
J Biol Chem; 2007 Jul; 282(28):20647-56. PubMed ID: 17504762
[TBL] [Abstract][Full Text] [Related]
8. Invariant Leu preceding turn motif phosphorylation site controls the interaction of protein kinase C with Hsp70.
Gao T; Newton AC
J Biol Chem; 2006 Oct; 281(43):32461-8. PubMed ID: 16954220
[TBL] [Abstract][Full Text] [Related]
9. PHLPPing through history: a decade in the life of PHLPP phosphatases.
Grzechnik AT; Newton AC
Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of the phosphatase domain of the tumor suppressor PH domain leucine-rich repeat protein phosphatase.
Sierecki E; Newton AC
Biochemistry; 2014 Jun; 53(24):3971-81. PubMed ID: 24892992
[TBL] [Abstract][Full Text] [Related]
11. Diacylglycerol kinase δ modulates Akt phosphorylation through pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2).
Crotty TM; Nakano T; Stafforini DM; Topham MK
J Biol Chem; 2013 Jan; 288(3):1439-47. PubMed ID: 23184957
[TBL] [Abstract][Full Text] [Related]
12. PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth.
Liu J; Stevens PD; Li X; Schmidt MD; Gao T
Mol Cell Biol; 2011 Dec; 31(24):4917-27. PubMed ID: 21986499
[TBL] [Abstract][Full Text] [Related]
13. Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis.
Liu J; Weiss HL; Rychahou P; Jackson LN; Evers BM; Gao T
Oncogene; 2009 Feb; 28(7):994-1004. PubMed ID: 19079341
[TBL] [Abstract][Full Text] [Related]
14. Active site inhibitors protect protein kinase C from dephosphorylation and stabilize its mature form.
Gould CM; Antal CE; Reyes G; Kunkel MT; Adams RA; Ziyar A; Riveros T; Newton AC
J Biol Chem; 2011 Aug; 286(33):28922-28930. PubMed ID: 21715334
[TBL] [Abstract][Full Text] [Related]
15. Protein Kinase C Quality Control by Phosphatase PHLPP1 Unveils Loss-of-Function Mechanism in Cancer.
Baffi TR; Van AN; Zhao W; Mills GB; Newton AC
Mol Cell; 2019 Apr; 74(2):378-392.e5. PubMed ID: 30904392
[TBL] [Abstract][Full Text] [Related]
16. Turning off AKT: PHLPP as a drug target.
Newton AC; Trotman LC
Annu Rev Pharmacol Toxicol; 2014; 54():537-58. PubMed ID: 24392697
[TBL] [Abstract][Full Text] [Related]
17. Suppression of survival signalling pathways by the phosphatase PHLPP.
O'Neill AK; Niederst MJ; Newton AC
FEBS J; 2013 Jan; 280(2):572-83. PubMed ID: 22340730
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.
Jackson TC; Verrier JD; Drabek T; Janesko-Feldman K; Gillespie DG; Uray T; Dezfulian C; Clark RS; Bayir H; Jackson EK; Kochanek PM
J Pharmacol Exp Ther; 2013 Nov; 347(2):516-28. PubMed ID: 24023368
[TBL] [Abstract][Full Text] [Related]
19. Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase output.
Reyes G; Niederst M; Cohen-Katsenelson K; Stender JD; Kunkel MT; Chen M; Brognard J; Sierecki E; Gao T; Nowak DG; Trotman LC; Glass CK; Newton AC
Proc Natl Acad Sci U S A; 2014 Sep; 111(38):E3957-65. PubMed ID: 25201979
[TBL] [Abstract][Full Text] [Related]
20. Photoreceptor Neuroprotection: Regulation of Akt Activation Through Serine/Threonine Phosphatases, PHLPP and PHLPPL.
Rajala RV; Kanan Y; Anderson RE
Adv Exp Med Biol; 2016; 854():419-24. PubMed ID: 26427440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
